Dr. Marty Makary Resigns as FDA Commissioner Amid Internal and External Criticism
Dr. Marty Makary has stepped down from his role as U.S. Food and Drug Administration (FDA) commissioner following widespread criticism from industry stakeholders, physicians, patient groups, and internal staff. His tenure was marked by leadership turmoil, declining morale at the FDA, and backlash over regulatory decisions affecting drug approvals and policy initiatives.
Topics: executive leadership FDA government regulation public health